Immunocore
(IMCR)
undefined
undefined%
At close: undefined
29.87
0.00%
After-hours Jan 06, 2025, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -43.37M | -41.22M | -131.52M | -74.09M | -103.93M | -71.63M |
| Depreciation & Amortization | 4.09M | 6.13M | 7.01M | 8.98M | 9.21M | 6.71M |
| Stock-Based Compensation | 32.47M | 32.89M | 48.89M | 8.16M | 3.06M | 666.00K |
| Other Working Capital | 5.78M | 19.20M | -11.66M | -28.27M | -11.92M | 67.58M |
| Other Non-Cash Items | 3.97M | -7.42M | -14.89M | 38.45M | 22.64M | -3.40M |
| Deferred Income Tax | n/a | -2.92M | -9.40M | -13.27M | -22.26M | -16.55M |
| Change in Working Capital | 5.78M | -12.88M | -16.81M | -28.80M | -10.09M | 67.58M |
| Operating Cash Flow | 2.94M | -31.27M | -129.75M | -60.57M | -101.38M | -16.63M |
| Capital Expenditures | -5.42M | -2.20M | -1.01M | -3.07M | -4.28M | -3.54M |
| Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | 27.45M |
| Other Investing Acitivies | -1.17M | 2.43M | 513.00K | 3.54M | 139.00K | 34.10M |
| Investing Cash Flow | -5.42M | 233.00K | -495.00K | 467.00K | -4.14M | 58.01M |
| Debt Repayment | n/a | n/a | n/a | 45.13M | -4.04M | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 34.35M | -1.29M | -10.63M | -145.23K | -711.00K | 101.00K |
| Financial Cash Flow | 34.35M | 138.23M | 276.25M | 115.94M | 55.13M | 101.00K |
| Net Cash Flow | 40.15M | 114.31M | 146.03M | 55.75M | -50.42M | 41.50M |
| Free Cash Flow | -2.48M | -33.47M | -130.76M | -63.65M | -105.65M | -20.16M |